2032年までの非動物代替試験の世界市場機会と戦略Including：1）技術別1）技術別：細胞培養技術、ハイスループット技術、分子イメージング、オミックス技術2）方法別：細胞アッセイ、生化学アッセイ、インシリコ、生体外3）エンドユーザー別：細胞アッセイ、生化学アッセイ、インシリコ、生体外3）エンドユーザー別：製薬産業、化粧品・家庭用品、診断薬、化学産業、食品・飲料産業：Evotec SE (Cyprotex); Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation

Non-Animal Alternatives Testing Global Market Opportunities And Strategies To 2032Including: 1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-Vivo3) By End-User: Pharmaceutical Industry; Cosmetics And Household Products; Diagnostics; Chemicals Industry; Food And Beverage IndustryCovering: Evotec SE (Cyprotex); Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation

この調査レポートは、COVID-19の閉鎖から立ち上がる世界の非動物代替試験市場を評価するために必要な重要情報を提供します。購入の理由 - 12地域をカバーするこの市場に関する最も包括的なレポートにより、... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Business Research Company　(TBRC) ザ・ビジネスリサーチカンパニー	2023年5月19日	US$5,000 シングルユーザライセンスライセンス・価格情報注文方法はこちら	367	英語

サマリー

この調査レポートは、COVID-19の閉鎖から立ち上がる世界の非動物代替試験市場を評価するために必要な重要情報を提供します。

購入の理由
- 12地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。
- 市場がコロナウイルスからどのような影響を受けているか、またウイルスの影響が和らぐにつれて市場がどのように立ち上がり、成長しそうかを理解する。
- 現地のデータと分析に基づき、地域別および国別の戦略を策定する。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。
- 最新の市場調査結果に基づいて顧客を理解する。
- 主要な競合他社とのパフォーマンスの比較
- 主要データセット間の関係を活用し、優れた戦略を立てる。
- 信頼性の高い高品質なデータと分析により、社内外のプレゼンテーションをサポートします。

説明
動物実験によらない代替検査で最も市場が大きく、急成長しているのはどこなのか？この市場は経済全体、人口動態、その他の類似市場とどのように関連しているのか？今後どのような力が市場を形成していくのか？ビジネスリサーチ社の非動物代替試験市場世界レポートは、これらすべての質問とその他多くの質問に回答します。
当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、市場の動向および戦略について記載しています。市場の歴史をたどり、地域別の市場成長を予測しています。また、同市場をより広範な非動物代替試験市場との関連において位置づけ、他市場との比較も行っています。

本レポートは以下の章をカバーしています。
- 序論と市場の特徴
非動物実験代替法市場について、市場細分化、定義、解説を簡単に紹介しています。
- 主要動向
世界の非動物実験代替法市場を形成している主要トレンドをハイライトしています。また、今後の市場動向についても取り上げます。
- 世界の市場規模と成長
世界の過去（2017年～2022年）、予測（2022年～2027年）、（2027年～2032年）市場価値、過去および予測期間における市場成長を支え、制御する推進要因と阻害要因。
- 地域別分析
地域別の過去（2017-2022年）および予測（2022-2027年）、（2027-2032年）市場価値と成長率、市場シェア比較。
- 市場セグメンテーション
市場における技術別、方法別、エンドユーザー別の市場価値（2017-2032）と各セグメント別の分析を収録。
- 地域別市場規模と成長
地域別の市場規模（2022年）、過去（2017年～2022年）および予測（2022年～2027年）、（2027年～2032年）の市場価値、地域内各国の成長率と市場シェア比較。本レポートには、アジア太平洋、西欧、東欧、北米、南米、中東、アフリカの全地域と各地域内の主要国に関する情報が含まれています。
- 競争環境
市場の競争状況、推定市場占有率、主要企業の会社プロファイルの詳細を掲載しています。
- 主要なM&A
本レポートでカバーしている市場における最近のM&Aに関する情報を掲載しています。本セクションでは、近年の市場を形成したM&Aに関する主要な財務情報を掲載しています。
- 市場機会と戦略
調査結果に基づく市場機会と戦略について、国やセグメントごとの成長機会や、それらの市場で取るべき戦略に関する情報を交えて記述しています。
- 結論と提言
本セクションでは、製品・サービスの提供地域拡大、マーケティング戦略、ターゲット層などの観点から、非動物代替試験プロバイダーへの提言を掲載しています。
- 付録
このセクションには、本レポートで使用したNAICSコード、略語、通貨コードの詳細が含まれています。

対象範囲
対象市場
1) 技術別細胞培養技術、ハイスループット技術、分子イメージング、オミックス技術、その他技術
2) 方法別細胞アッセイ、生化学アッセイ、インシリコ、エクスビボ
3) エンドユーザー別：製薬業界、化粧品・日用品、診断薬、化学業界、食品・飲料業界、その他エンドユーザー

言及された企業Evotec SE (Cyprotex); Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation

国中国、オーストラリア、インド、インドネシア、日本、韓国、アメリカ、ブラジル、フランス、ドイツ、イギリス、ロシア

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列：過去5年間および過去10年間の予測。

データ関連市場に対する市場規模および成長率の比率、GDP比率、一人当たり支出、非動物代替試験指標の比較。

データ区分：国別および地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。

本レポートでは、非動物代替試験市場について説明し、2017-2022年を過去期間、2022-2027年を予測期間とし、2027-2032年のさらなる予測も含めて記載しています。各地域および各地域内の主要経済圏の市場を評価しています。

世界の非動物代替検査市場は、2017年以降年平均成長率（CAGR）9.5％で成長し、2022年には約18億6,370万ドルに達した。同市場は、2022年の18億6,370万ドルから2027年には32億2,250万ドルに11.6%の成長率で拡大すると予想される。その後、2027年からCAGR 11.5%で成長し、2032年には55億6,170万ドルに達すると予想される。

歴史的期間の成長は、新興市場における力強い経済成長、動物実験にかかる高コスト、基礎研究におけるin-vitroおよびin-silico技術の採用増加、代替技術開発のための投資増加および研究助成金の増加、動物虐待に対する社会的意識の高まりに起因する。

今後は、動物実験を行わない代替試験のための政府プログラム、研究開発活動の増加、動物実験に対する倫理的な懸念が成長を促進するだろう。今後、非動物代替試験市場の成長を阻害する要因としては、in vivo試験に対するin vitro試験の予測能力の欠如、OOC技術開発のための熟練したリソースの必要性の高まりなどが挙げられる。

非動物代替検査市場は、技術別に細胞培養技術、ハイスループット技術、分子イメージング技術、オミックス技術、その他の技術に区分される。細胞培養技術市場は、技術別に区分された非動物代替検査市場において最大のセグメントであり、2022年には全体の51.8%を占めた。今後、その他の技術分野は、技術別に区分された非動物代替検査市場において最も急速に成長する分野であり、2022〜2027年のCAGRは16.3％になると予想される。

非動物代替検査市場は、方法別に細胞アッセイ、生化学アッセイ、インシリコ、生体外に区分される。細胞アッセイ市場は、方法別に区分された非動物代替検査市場の中で最大のセグメントであり、2022年には全体の42.3%を占めた。今後、2022-2027年のCAGRは12.1%で、方法別に区分された非動物代替検査市場において、生体外セグメントが最も急成長するセグメントとなる見込みである。

非動物代替物試験市場は、エンドユーザー別に製薬産業、化粧品・家庭用品、診断、化学産業、食品・飲料産業、その他のエンドユーザーに区分される。製薬産業市場は、エンドユーザー別に区分された非動物代替検査市場の中で最大のセグメントであり、2022年には全体の40.6%を占めた。今後、製薬産業セグメントは、エンドユーザー別にセグメント化された非動物代替検査市場において、2022〜2027年のCAGR12.0%で最も急成長するセグメントとなる見込みである。

北米は非動物代替検査市場において最大の地域であり、2022年には全体の34.5%を占めた。次いで西ヨーロッパ、その他の地域と続く。今後、非動物代替検査市場で最も成長率が高い地域は中東とアジア太平洋で、それぞれ年平均成長率は14.4%と13.7%となる。これに続くのはアフリカと東欧で、それぞれCAGR 11.9％と11.4％の成長が見込まれる。

非動物実験代替検査市場は断片化されており、小規模な企業が多数存在する。同市場における上位10社の競合企業は、2021年の市場全体の7.45%を占めている。Evotec SE（Cyprotex）が市場シェア2.84%で最大の競合企業であり、Bio-Rad Laboratories, Inc.が1.27%、BioIVTが0.80%、Emulate, Inc.が0.71%、MatTek Corporationが0.38%、SGS SAが0.36%、Gentronix Limitedが0.30%、Promega Corporationが0.29%、InSpheroが0.25%、VITROCELL Systems GmbHが0.25%と続く。

非動物代替検査市場を技術別にセグメント化すると、2027年までに世界の年間売上高が7億370万ドルに達する細胞培養技術セグメントで最大のビジネスチャンスが生まれる。方法別に区分した非動物代替検査市場における最大のビジネスチャンスは、2027年までに世界の年間売上高が5億8,110万ドルに達する細胞アッセイセグメントにもたらされるであろう。エンドユーザー別に区分した非動物代替検査市場における最大のビジネスチャンスは製薬産業セグメントにあり、2027年までに世界全体の年間売上高が5億7610万ドルに達するだろう。非動物実験代替法市場規模は4億1,740万ドルで米国が最も大きくなる。

非動物代替試験市場の市場トレンドに基づく戦略には、OOC技術の進歩への注力、インシリコ試験の利用への注力、高度な3Dバイオプリント臓器・組織の開発、モデル生物の利用、共同研究・パートナーシップ、動物実験フリー推進のためのイニシアティブや助成金の増加などが含まれる。

非動物実験代替法市場で採用されている戦略としては、同業他社の買収による技術・研究開発力の拡大、in vivoや別の実験用システムの投入による事業強化、同業他社の買収による事業強化、事業投資による製品ポートフォリオの強化、同業他社との提携による3Dバイオ製造やin vitro分析サービスの認知度向上などが挙げられる。

ビジネスリサーチカンパニーは、このようなビジネスチャンスを活かすため、非動物代替検査企業に対し、OOC（臓器オンチップ）ツールへの注力、インシリコ試験の活用への注力、モデル生物の活用への注力、3Dプリント臓器への注力、新興市場での事業確立、パートナーシップやコラボレーションへの注力、価格競争力のある製品の提供、B2Bプロモーションの継続、急成長するエンドユーザーへの継続的なアプローチを推奨している。

ページTOPに戻る

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction And Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Non-Animal Alternatives Testing Market Definition And Segmentations
6.4. Market Segmentation By Technology
6.4.1. Cell Culture Technology
6.4.2. High Throughput Technology
6.4.3. Molecular Imaging
6.4.4. Omics Technology
6.4.5. Other Technologies
6.5. Market Segmentation By Method
6.5.1. Cellular Assay
6.5.2. Biochemical Assay
6.5.3. In Silico
6.5.4. Ex-Vivo
6.6. Market Segmentation By End-User
6.6.1. Pharmaceutical Industry
6.6.2. Cosmetics And Household Products
6.6.3. Diagnostics
6.6.4. Chemicals Industry
6.6.5. Food And Beverage Industry
6.6.6. Other End-Users
7. Major Market Trends
7.1. Developments In OOC (Organ-On-Chip) For Testing
7.2. Adoption Of In Silico Trials
7.3. Use Of Model Organisms
7.4. Focus On 3D-Printed Organs For Testing
7.5. Increasing Collaborations And Partnerships To Reduce Animal Testing
7.6. Rising Initiatives And Grants To Promote Animal-Free Testing
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
8.2.1. Market Drivers 2017 – 2022
8.2.2. Market Restraints 2017 – 2022
8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 – 2027
8.3.2. Market Restraints 2022 – 2027
9. Global Non-Animal Alternatives Testing Market Segmentation
9.1. Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. Non-Animal Alternatives Testing Market, Regional and Country Analysis
10.1. Global Non-Animal Alternatives Testing Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Non-Animal Alternatives Testing Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.4. Asia-Pacific Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Non-Animal Alternatives Testing Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate tax structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.13. China Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.14. China Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.15. China Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.16. China Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.19. India Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.20. India Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.21. India Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.22. India Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.25. Japan Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.26. Japan Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.31. Australia Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.32. Australia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.37. Indonesia Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.38. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.43. South Korea Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.44. South Korea Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Western Europe Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Non-Animal Alternatives Testing Market: Country Analysis
12.9. UK Market
12.10. UK Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.11. UK Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.12. UK Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.17. Germany Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.18. Germany Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.23. France Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.24. France Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.25. France Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.26. France Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Eastern Europe Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Non-Animal Alternatives Testing Market: Country Analysis
13.9. Russia Market
13.10. Russia Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. Russia Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. Russia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. North America Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. North America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Non-Animal Alternatives Testing Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.13. USA Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.14. USA Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Major Companies
15.3. South America Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. South America Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. South America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Non-Animal Alternatives Testing Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.11. Brazil Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.12. Brazil Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. Middle East Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. Middle East Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Major Companies
17.3. Africa Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Africa Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Africa Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles
19. Company Profiles
19.1. Evotec SE
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Business Strategy
19.1.4. Financial Overview
19.2. Bio-Rad Laboratories Inc
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. BioIVT
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
19.4. Emulate, Inc
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. MatTek Corporation
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Business Strategy
19.5.4. Financial Overview
20. Key Mergers And Acquisitions
20.1. AnaBios Acquired Cell Systems
20.2. Molecular Devices LLC Acquired Cellesce Ltd.
20.3. Angus Chemical Company Acquired Expression Systems
20.4. Cytiva Acquired CEVEC Pharmaceuticals
20.5. Evotec Acquired Rigenerand
20.6. SenzaGen Acquired VitroScreen S.r.l.
20.7. Bico Group Acquired HUREL Micro Liver Technologies
20.8. Bruker Acquired Canopy Biosciences, LLC
20.9. Sartorius Acquired Xell AG
20.10. Bio-Techne Acquired Asuragen Inc.
20.11. PerkinElmer Acquired Immunodiagnostic Systems Holdings PLC
20.12. Agilent Acquired Resolution Bioscience
20.13. Certara Acquired Silico Biosciences Inc.
21. Opportunities And Strategies
21.1. Global Non-Animal Alternatives Testing Market In 2027 – Countries Offering Most New Opportunities
21.2. Global Non-Animal Alternatives Testing Market In 2027 – Segments Offering Most New Opportunities
21.3. Global Non-Animal Alternatives Testing Market In 2027 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Non-Animal Alternatives Testing Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. The Business Research Company
23.5. Copyright and Disclaimer

ページTOPに戻る

Table of Contents

Summary

Non-Animal Alternatives Testing Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global non-animal alternatives testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:
Where is the largest and fastest-growing market for non-animal alternatives testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The non-animal alternatives testing market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider non-animal alternatives testing market; and compares it with other markets.

The report covers the following chapters
• Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the non-animal alternatives testing market.
• Key Trends
Highlights the major trends shaping the global non-animal alternatives testing market. This section also highlights likely future developments in the market.
• Global Market Size and Growth
Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional Analysis
Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
• Market Segmentation
Contains the market values (2017-2032) and analysis for each segment by technology, by method and by end-user in the market.
• Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations
This section includes recommendations for non-animal alternatives testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope
Markets Covered:
1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology; Other Technologies
2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-Vivo
3) By End-User: Pharmaceutical Industry; Cosmetics And Household Products; Diagnostics; Chemicals Industry; Food And Beverage Industry; Other End Users

Companies Mentioned: Evotec SE (Cyprotex); Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; non-animal alternatives testing indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report describes and explains the non-animal alternatives testing market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.

The global non-animal alternatives testing market reached a value of nearly $1,863.7 million in 2022, having grown at a compound annual growth rate (CAGR) of 9.5% since 2017. The market is expected to grow from $1,863.7 million in 2022 to $3,222.5 million in 2027 at a rate of 11.6%. The market is then expected to grow at a CAGR of 11.5% from 2027 and reach $5,561.7 million in 2032.

Growth in the historic period resulted from strong economic growth in emerging markets, the high costs of animal studies, the increasing adoption of in-vitro and in-silico technologies in basic research, the rising investments and the rise in research grants for developing alternative technologies and the increasing social awareness against animal cruelty.

Going forward, government programs for non-animal alternative testing, the rise in the number of research and development activities and ethical concerns on animal experimentations will drive the growth. Factors that could hinder the growth of the non-animal alternatives testing market in the future include lack of predictive ability of in vitro testing over in vivo testing and the rise in need for skilled resources for the development of OOC technology.

The non-animal alternatives testing market is segmented by technology into cell culture technology, high throughput technology, molecular imaging, omics technology and other technologies. The cell culture technology market was the largest segment of the non-animal alternatives testing market segmented by technology, accounting for 51.8% of the total in 2022. Going forward, the other technologies segment is expected to be the fastest growing segment in the non-animal alternatives testing market segmented by technology, at a CAGR of 16.3% during 2022-2027.

The non-animal alternatives testing market is segmented by method into cellular assay, biochemical assay, in silico, and ex-vivo. The cellular assay market was the largest segment of the non-animal alternatives testing market segmented by method, accounting for 42.3% of the total in 2022. Going forward, the ex-vivo segment is expected to be the fastest growing segment in the non-animal alternatives testing market segmented by method, at a CAGR of 12.1% during 2022-2027.

The non-animal alternatives testing market is segmented by end-user into pharmaceutical industry, cosmetics and household products, diagnostics, chemicals industry, food and beverage industry and other end users. The pharmaceutical industry market was the largest segment of the non-animal alternatives testing market segmented by end-user, accounting for 40.6% of the total in 2022. Going forward, the pharmaceutical industry segment is expected to be the fastest growing segment in the non-animal alternatives testing market segmented by end-user, at a CAGR of 12.0% during 2022-2027.

North America was the largest region in the non-animal alternatives testing market, accounting for 34.5% of the total in 2022. It was followed by Western Europe, and then the other regions. Going forward, the fastest-growing regions in the non-animal alternatives testing market will be the Middle East and Asia Pacific where growth will be at CAGRs of 14.4% and 13.7% respectively. These will be followed by Africa and Eastern Europe where the markets are expected to grow at CAGRs of 11.9% and 11.4% respectively.

The non-animal alternatives testing market is fragmented, with a large number of small players. The top ten competitors in the market made up to 7.45% of the total market in 2021. Evotec SE (Cyprotex) was the largest competitor with 2.84% share of the market, followed by Bio-Rad Laboratories, Inc. with 1.27%, BioIVT with 0.80%, Emulate, Inc with 0.71%, MatTek Corporation with 0.38%, SGS SA with 0.36%, Gentronix Limited with 0.30%, Promega Corporation with 0.29%, InSphero with 0.25%, and VITROCELL Systems GmbH with 0.25%.

The top opportunities in the non-animal alternatives testing market segmented by technology will arise in the cell culture technology segment, which will gain $703.7 million of global annual sales by 2027. The top opportunities in the non-animal alternatives testing market segmented by method will arise in the cellular assay segment, which will gain $581.1 million of global annual sales by 2027. The top opportunities in the non-animal alternatives testing market segmented by end-user will arise in the pharmaceutical industry segment, which will gain $576.1 million of global annual sales by 2027. The non-animal alternatives testing market size will gain the most in USA at $417.4 million.

Market-trend-based strategies for the non-animal alternatives testing market include focus on advancing OOC technology, focus on use of in silico trials, developing advanced 3D bio-printed organs and tissues, use of model organisms, collaborations and partnerships, and rising initiatives and grants to promote animal-free testing.

Player-adopted strategies in the non-animal alternatives testing market include expanding technology and research and development capabilities by acquiring companies with the same business, strengthening business by launching systems for in vivo and another testing, strengthening business by acquiring companies with the same business, strengthening product portfolio by investing in business, and increasing awareness about 3D biomanufacturing and in vitro analysis services by collaborating with companies having the same business.

To take advantage of the opportunities, The Business Research Company recommends the non-animal alternatives testing companies to focus on OOC (organ-on-chip) tools, focus on use of in silico trials, focus on use of model organisms, focus on 3D-printed organs, establish operations in emerging markets, focus on partnerships and collaborations, provide competitively priced offerings, continue to use B2B promotions and continue to target fast-growing end-users.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

The Business Research Company　(TBRC)社の医療サービス分野での最新刊レポート

本レポートと同じKEY WORD（cellular）の最新刊レポート

よくあるご質問

The Business Research Company　(TBRC)社はどのような調査会社ですか?

The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

The Business Research Company (TBRC)社の医療サービス分野での最新刊レポート

本レポートと同じKEY WORD（cellular）の最新刊レポート

よくあるご質問

The Business Research Company (TBRC)社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?

The Business Research Company　(TBRC)社の医療サービス分野での最新刊レポート

The Business Research Company　(TBRC)社はどのような調査会社ですか?